Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)
Public ClinicalTrials.gov record NCT01844518. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Multi-center, Open-Label Study to Evaluate Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)
Study identification
- NCT ID
- NCT01844518
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 219 participants
Conditions and interventions
Interventions
- Abatacept Biological
Biological
Eligibility (public fields only)
- Age range
- 2 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 29, 2013
- Primary completion
- Mar 11, 2015
- Completion
- Jan 31, 2023
- Last update posted
- Jul 11, 2023
2013 – 2023
United States locations
- U.S. sites
- 12
- U.S. states
- 12
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0007 | Birmingham | Alabama | 35233-1711 | — |
| Local Institution - 0003 | Little Rock | Arkansas | 72202 | — |
| Local Institution - 0011 | Hartford | Connecticut | 06106 | — |
| Local Institution - 0009 | Chicago | Illinois | 60637 | — |
| Riley Hospital For Children | Indianapolis | Indiana | 46202 | — |
| University Of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Local Institution - 0001 | Kansas City | Missouri | 64108 | — |
| Local Institution - 0002 | The Bronx | New York | 10467 | — |
| Local Institution - 0008 | Cincinnati | Ohio | 45229 | — |
| Local Institution - 0005 | Portland | Oregon | 97227 | — |
| Local Institution - 0004 | Salt Lake City | Utah | 84132 | — |
| Seattle Children'S Hospital | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01844518, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 11, 2023 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01844518 live on ClinicalTrials.gov.